Clearstead Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-500
| Closed | -$545 | – | 1375 |
|
|
2023
Q1 | $545 | Hold |
500
| – | – | ﹤0.01% | 1292 |
|
|
2022
Q4 | $730 | Hold |
500
| – | – | ﹤0.01% | 1196 |
|
|
2022
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 1118 |
|
|
2022
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q1 | $1K | Hold |
500
| – | – | ﹤0.01% | 1257 |
|
|
2021
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 1085 |
|
|
2021
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 1065 |
|
|
2021
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 1009 |
|
|
2021
Q1 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 908 |
|